Related references
Note: Only part of the references are listed.Double-carbapenem regimen, alone or in combination with colistin, in the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp)
Alessandra Oliva et al.
JOURNAL OF INFECTION (2017)
Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae
A. Oliva et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit
Giancarlo Ceccarelli et al.
BMC INFECTIOUS DISEASES (2015)
Colistin resistance in Klebsiella pneumoniae
Young-Mi Ah et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections
Alessandra Oliva et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates
Paolo Gaibani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae
Helen Giamarellou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Synergistic Activity of Colistin plus Rifampin against Colistin-Resistant KPC-Producing Klebsiella pneumoniae
Carlo Tascini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality
A. Capone et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art
Nicola Petrosillo et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
L. Silvia Munoz-Price et al.
LANCET INFECTIOUS DISEASES (2013)
The Combination of Doripenem and Colistin Is Bactericidal and Synergistic against Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae
Meredith G. Jernigan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2012)
Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
Catharine C. Bulik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Comparative Effectiveness of Aminoglycosides, Polymyxin B, and Tigecycline for Clearance of Carbapenem-Resistant Klebsiella pneumoniae from Urine
Michael J. Satlin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System
Jason M. Pogue et al.
CLINICAL INFECTIOUS DISEASES (2011)
In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii
J Yoon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Share Paper
